Key terms include: $150 million upfront payment to Yao Pharma Up to $1.935 billion in development, regulatory, and commercial milestone payments Tiered royalties on future global sales Coverage across all therapeutic, diagnostic, and prophylactic indications for both human and veterinary use This structure positions the agreement as one of the larger oral-GLP-1 licensing deals in recent years
Ranked by Best Law Firms in Regional Tier 1, New Orleans, in Construction Law, DArcy Vicknair LLC has distinguished itself in the legal industry, earning this prestigious accolade
Around 15.5 million people, or 6% of adults in the U.S., say theyve tried GPL-1 weight loss drugs, according to a Gallup poll
Is retatrutide approved everywhere
Ready to discover which peptide stack is right for you